Swapan Ray to Combined Modality Therapy
This is a "connection" page, showing publications Swapan Ray has written about Combined Modality Therapy.
Connection Strength
0.332
-
Experimental Procedures for Demonstration of MicroRNA Mediated Enhancement of Functional Neuroprotective Effects of Estrogen Receptor Agonists. Methods Mol Biol. 2016; 1366:359-372.
Score: 0.108
-
Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo. Neuro Oncol. 2010 Nov; 12(11):1088-101.
Score: 0.074
-
Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth. J Cell Mol Med. 2009 Oct; 13(10):4205-18.
Score: 0.070
-
Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochem Res. 2007 Dec; 32(12):2203-9.
Score: 0.060
-
Drug resistance in glioblastoma: a mini review. Neurochem Res. 2012 Jun; 37(6):1192-200.
Score: 0.020